Articles

Find an Article

Filter articles

Applied Filters

Showing 231 to 240 of 273 results

Combating cancer: Apexigen and rabbit antibodies

US28-02-2014

Apexigen uses antibodies derived from rabbits to develop therapies for diseases that are difficult to treat. LSIPR found out how it protects its novel technologies.

More bang for your buck: second medical use and the EPC 2000

EU19-02-2014Caroline Pallard

Second and further medical use claims provide companies and patent lawyers with interesting opportunities, as Caroline Pallard explains.

Aiming high: Canadian biotech

Canada03-02-2014

In a global league, Canada’s biotech industry would be respectably mid table. LSIPR talks to Andrew Casey, president of industry association BIOTECanada, about how the organisation is trying to take it to the next level.

Cellular Dynamics: cells to order

US13-01-2014

Stem cells are seen by many as the great hope for medical research in the years to come. LSIPR spoke to Nicholas Seay, chief technology officer at Cellular Dynamics, about the importance of IP in this field.

Patenting diagnostic methods post-Myriad

US03-12-2013Antoinette Konski

The first US court decision applying the Myriad decision has landed, and it makes for interesting reading, as Antoinette Konski reports.

New frontiers: potential barriers to patenting induced totipotent stem cell technology

EU04-11-2013

Ethical considerations plus the ambiguity of the Biotech Directive are factors influencing the patentability of totipotent stem cells, says Andrew Sanderson.

New horizons: biotech guidelines in Brazil

Brazil16-10-2013Gabriel Di Blasi and Alexandre Santos

New guidelines for the examination of biotechnology inventions in Brazil provide useful support for applicants, as Gabriel Di Blasi and Alexandre Santos explain.

Protecting plant products in Europe

EU16-10-2013Frances Salisbury and Lindsey Woolley

Frances Salisbury and Lindsey Woolley look at the complex business of patenting agricultural products in Europe.

Patents for self-replicating products: not so exhausting after all

EU16-10-2013

When the US Supreme Court decided in favour of Monsanto in its case against a soybean farmer, it clarified the patent status of certain self-replicating technologies. In Europe, the result would probably have been the same, say Steven Zeman and Heike Vogelsang-Wenke.

Salad days: tomatoes, broccoli and radish patents

EU16-10-2013Margreet van Heuvel and Bart Swinkels

When it comes to plants, European courts have been occupied with various debates over salad. Margreet van Heuvel and Bart Swinkels take a look.

Showing 231 to 240 of 273 results

LSIPR